is specific for kinetochores from nuclear envelope breakdown (NEB) to metaphase. Previous work suggests that pT89 dynein is recruited to kinetochores through a direct interaction with zw10, but undergoes dephosphorylation in response to bi-oriented microtubule attachment and chromosome alignment. This dephosphorylation of dynein shifts binding to dynactin and stimulates poleward transport of checkpoint proteins -a transition required for the silencing of the spindle assembly checkpoint at metaphase. Defects in this process induce metaphase arrest/delay.
Kinetochore dynein has been implicated in microtubule capture, correcting inappropriate microtubule attachments, chromosome movement and checkpoint silencing. It remains unclear how dynein coordinates this diverse set of functions. Phosphorylation is responsible for some dynein heterogeneity [1], and phosphorylated and dephosphorylated forms of dynein coexist at prometaphase kinetochores. In this study, we measured the impact of inhibiting polo-like kinase 1 (Plk1) on both dynein populations. Phosphorylated dynein was ablated at kinetochores after inhibiting Plk1 with a small molecule inhibitor (BTO-1) or chemical genetic approaches. The total complement of kinetochore dynein was also reduced but not eliminated, reflecting the presence of some dephosphorylated dynein after Plk1 inhibition. Although Plk1 inhibition had a profound effect on dynein, kinetochore populations of dynactin, spindly and zw10 were not reduced. Plk1-independent dynein was reduced after p150
Glued depletion, consistent with the binding of dephosphorylated dynein to dynactin. Plk1 phosphorylated dynein intermediate chains (ICs) at T89 in vitro and generated the pT89 phospho-epitope on recombinant dynein ICs. Finally, inhibition of Plk1 induced defects in microtubule capture and persistent microtubule attachment, suggesting a role for phosphorylated dynein in these functions during prometaphase. These findings suggest that Plk1 is a dynein kinase required for recruitment of phosphorylated dynein to kinetochores.
Cytoplasmic dynein plays important roles at spindle poles, the cell cortex and kinetochores during mitosis. The mechanisms that allow dynein to associate specifically with each site remain unknown. One possibility is suggested by the identification of a novel mitotic phosphorylation site in the dynein intermediate chains (ICs) [1]. This phosphorylated form of dynein (pT89) is specific for kinetochores from nuclear envelope breakdown (NEB) to metaphase. Previous work suggests that pT89 dynein is recruited to kinetochores through a direct interaction with zw10, but undergoes dephosphorylation in response to bi-oriented microtubule attachment and chromosome alignment. This dephosphorylation of dynein shifts binding to dynactin and stimulates poleward transport of checkpoint proteins -a transition required for the silencing of the spindle assembly checkpoint at metaphase. Defects in this process induce metaphase arrest/delay.
One prediction of this model is that dynein could interact with multiple proteins at kinetochores depending on the degree of microtubule attachment, microtubule occupancy and chromosome alignment. Consistent with this scenario, several mitotic proteins have been implicated in interacting with or anchoring kinetochore dynein including dynactin [2] , zw10 [1, 3] , spindly [4, 5] , LIS-1 [6] , nudE/EL [7] [8] [9] and nudC [10] . Some of these proteins are likely to affect dynein regulation [11] or motility [1] . The contribution of remaining proteins is under investigation. Zw10 emerges as a central player in dynein recruitment and has been shown to interact with dynactin [12] , spindly [4, 5] and nudE/EL [13] . The identification of a direct interaction between phosphorylated dynein (pT89) and zw10 [1] provides additional support for zw10 and the rod-zw10-zwilch complex (RZZ) in dynein recruitment.
Given the complexity of the dynein motor and the multiple roles for dynein during mitosis, new approaches that deplete kinetochore dynein specifically without affecting dynein-associated proteins would improve analysis of dynein function. In this study, we used inhibition of dynein phosphorylation as a tool to reduce kinetochore dynein. Inhibition of Plk1 was sufficient to ablate pT89 dynein accumulation at kinetochores and to induce defects in initial microtubule capture and persistent attachment. In contrast, Plk1 inhibition did not reduce levels of zw10 or other dynein binding proteins. Finally, Plk1 was able to phosphorylate dynein ICs at T89 and create the pT89 phospho-epitope. Together these studies suggest that Plk1 is a dynein kinase required for recruitment of dynein to kinetochores.
EXPERIMENTAL PROCEDURES Chemicals and Reagents:
Chemicals were obtained from SigmaAldridge (St. Louis, MO) unless indicated otherwise. BTO-1 (EMD, Gibbstown, NJ) was used at a final concentration of 20µM. Antibodies against the dynein ICs [14] , phospho-dynein (pT89[1]), p150
Glued [15] and zw10 [16] and tubulin [1] were described previously. Commercially-available antibodies were obtained for BubR1 (BD Biosciences, San Jose, CA) and Spindly (Novus, Littleton, CO).
Immunofluorescence Microscopy of Cells:
NRK-2 and HeLa cells were maintained as described [1] . Cells growth on glass coverslips were prepared by MeOH fixation and stained with antibodies against cytoplasmic dynein ICs, the p150
Glued subunit of dynactin, BubR1, zw10 and spindly as described previously [ Figure Legends .
In Vitro Kinase Assays:
A truncated IC-2 recombinant protein was subjected to in vitro phosphorylation as previously described [1] using purified Plk1 (Cell Signaling, Danvers, MA or Cedarlane Inc., Burlington, NC) and subjected to autoradiography.
Analogue-sensitive Plk1 Constructs:
Wild-type and analogue-sensitive Plk1 constructs [17] were transfected by nucleoporation as described previously [1] . Transfected cells were treated with 3MB-PP1 [17] . Chilling/Re-warming Assays:
Time-lapse images of NRK cells were captured using a Leica DM RXA2 microscope (Leica Microsystems, Bannockburn, IL) with a Plan Apo 63x/1.3 NA/37 ˚C glycerol immersion objective enclosed in a custommade Plexiglas box maintained at 37 ˚C and a Hamamatsu ORCA-ER CCD camera (Hamamatsu Photonics, Hamamatsu, Japan). When the chromosomes were judged to have aligned, either vehicle (DMSO) or BTO-1 was added to the custom-built imaging chamber [18] and then the chamber was chilled (-20°C for 5 mins. followed by 35 mins. at 4°C [19] ).The chamber was re-warmed on the microscope for time-lapse imaging and a nosepiece diamond scribe was used to mark the cell position. After methanol fixation, cells were stained using anti-tubulin and pT89 antibodies.
Statistical Analysis:
Statistical analysis of intensity measurements was performed in Microsoft Excel. P-values of comparisons between control and experimental measurements were determined with a two-tailed t-test assuming unequal variance. Confidence levels were chosen at p<=0.05.
RESULTS

Impact of Plk1 Inhibition on Kinetochore Dynein:
The sequences surrounding the pT89 mitotic dynein phosphorylation site overlap with consensus sites for proline-directed kinases (X-S/T-P-X) and a polo-binding domain (X-S/T-pS/T-P-X). The latter is thought to represent a binding domain for polo-like kinases [20] . To test if Plk1 activity plays a role in generating pT89 at kinetochores, we treated NRK-2 cells with the small molecule inhibitor BTO-1 [21] . This inhibitor has been used to study Plk1 activities at other stages of mitosis [21] . Because the levels of pT89 dynein change as chromosomes begin to align at the metaphase plate [1], we measured the impact of BTO-1 treatment early in prometaphase. This allows a comparison of kinetochore dynein levels across the entire complement of chromosomes [1] . BTO-1 treatment reduced the levels of pT89 dynein at kinetochores significantly and also reduced the cytoplasmic pool which is detected normally (Fig. 1A) . The latter suggests that BTO-1 treatment reduces phosphorylation of dynein at pT89 rather than inhibiting the accumulation of pT89 at kinetochores.
Small molecule inhibitors are powerful tools to study candidate kinases, especially kinases such as Plk1 that are essential and required for multiple stages of mitosis. However, the absolute specificity of some inhibitors is not understood completely. To complement studies with BTO-1, we used analogue-sensitive constructs (AS-Plk1) together with nucleotide analogues (3MB-PP1) to inhibit Plk1 [17] . The strength of this approach is the specificity of the drugs for the nucleotide binding pocket of mutated Plk1 constructs. In contrast to cells expressing WT-Plk1, cells expressing the AS-Plk1 and treated with 3MB-PP1 displayed a marked reduction in pT89 staining (Fig. 1B ) comparable to BTO-1 treatment alone (Fig.  1A) . The loss of a cytoplasmic pool of pT89 staining also matched BTO-1 treatment, consistent with a reduction in phosphorylation rather than a reduction in recruitment alone. The similarities in staining for pT89 between BTO-1 and expression of AS-Plk1 constructs suggests that Plk1 is required for recruitment of pT89 dynein to kinetochores during prometaphase.
Multiple Populations of Dynein at Kinetochores:
BTO-1 treatment reduced phosphorylated dynein (pT89) at kinetochores, however ongoing studies suggest that dephosphorylated dynein could also accumulate at kinetochores [1] . To test this hypothesis, we measured the impact of reducing phosphorylated dynein on accumulation of total dynein. In comparison to controls, levels of total dynein were also reduced significantly after Plk1 inhibition ( Fig.  2A) . Peak kinetochore intensities were reduced ~30%. Interestingly however, levels of total dynein were not ablated completely, suggesting the presence of some dephosphorylated dynein on kinetochores even after Plk1 inhibition.
One feature of dephosphorylated dynein is direct binding to the dynactin complex [1, 14] . To test if the BTO-1-resistant population of dynein was dependent on dynactin, we used shRNA-driven depletion of p150
Glued to reduce the dynactin complex at kinetochores. As indicated above, Plk1 inhibition alone reduced the levels of total dynein at kinetochores but still permitted some accumulation of dynein. Consistent with previous studies demonstrating a role for dynactin in anchoring a subset of kinetochore dynein [2] , BTO-1 treatment coupled with dynactin depletion resulted in a comprehensive loss of dynein at kinetochores (Fig. 2B ). This suggests that the residual accumulation of dynein after Plk1 inhibition represents a dephosphorylated form of dynein bound to dynactin.
Impact of Plk1 Inhibition on Dyneinassociated Proteins:
BTO-1 treatment appeared to reduce accumulation of pT89 dynein at kinetochores by reducing phosphorylation (Figs. 1 & 2) , however other mechanisms could explain the reduction, including loss of candidate dyneinassociated proteins. To test this possibility, we performed IFM analysis on BTO-1 treated cells and measured levels of dynactin, spindly and zw10. BTO-1 treatment did not have a significant impact on the accumulations of p150
Glued (dynactin), spindly or zw10 at kinetochores (Fig. 3 ). Because these represent the core dynein-binding proteins at kinetochores, these results suggest that BTO-1 treatment does not disrupt the overall structure of the dynein-binding platform at kinetochores but rather affects the ability of this platform to recruit dynein.
In Vitro Phosphorylation of Dynein by Plk1:
We also considered the possibility that Plk1 inhibition affected dynein recruitment without impacting the phosphorylation of dynein itself.
To test if Plk1 could phosphorylate the dynein ICs directly, we used in vitro kinase reactions with recombinant ICs (Fig. 4) . The ICs displayed phosphorylation by Plk1 in vitro and this was demonstrated using Plk1 from two different commercial courses (Fig.  4A ). Phosphorylation was reduced in reactions with the T89A mutant (Fig. 4A ) and quantification revealed a significant reduction in 32 P-incoroporation (Fig. 4B) Previous studies on kinetochore dynein function have either inhibited dynein globally [22] or disrupted dynein binding proteins [2] [3] [4] [5] [6] [7] 23] . One benefit of identifying the kinase responsible for kinetochore dynein phosphorylation is the ability to block dynein recruitment without affecting other dyneinbinding proteins. To assess the impact of reduced kinetochore dynein on prometaphase progression, we measured errors in kinetochore activity after BTO-1 treatment using live cell imaging. Because Plk1 is required for prophase functions including spindle pole separation, we added BTO-1 to cells approaching NEB and performed timelapse imaging (Fig. 5) . In contrast to controls which progressed from NEB to metaphase within ~16 minutes, BTO-1 treated cells displayed multiple delays and defects during prometaphase (Fig. 5) . The most common error was delayed attachment of kinetochores to the mitotic spindle. In addition, once chromosomes approached the metaphase plate, individual chromosomes lost microtubule attachment transiently. Both of these defects extended the time needed to achieve metaphase alignment, and the time from NEB to metaphase completion increased from ~16 min, to ~28 min. This is similar to phenotypes observed when dynein is disrupted using dominant-negative DHC constructs [22] , but different from the phenotypes elicited by p50(dynamitin) expression (ie. metaphase arrest/delay [2] [19] . The kinetochores of these control cells displayed labeling for pT89 dynein at levels similar to unattached kinetochores (Fig. 6 ). This indicates that kinetochores retain the ability to recruit pT89 dynein, even after alignment has been achieved. The requirement for Plk1 activity was tested by adding BTO-1 to the cells during the chilling step. Despite the reformation of a typical mitotic spindle in BTO-1-treated cells, kinetochores did not accumulate pT89 dynein after re-warming (Fig. 6 ). Together these chilling/re-warming experiments reveal that kinetochores retain the ability to recruit dynein throughout prometaphase and into metaphase. This suggests that the changes in pT89 accumulation reflect the dynamics of dynein dephosphorylation and streaming rather than a fundamental change in dynein recruitment activities. DISCUSSION These studies provide additional support for the role of phosphorylation in recruitment of cytoplasmic dynein to kinetochores during mitosis and identify a dynein kinase required for this recruitment. Inhibition of Plk1 blocks recruitment of phosphorylated dynein to kinetochores and affects the total pool of dynein at kinetochores significantly. The overall structure of the dynein-binding platform is not affected dramatically, however. Plk1 can phosphorylate the dynein ICs in vitro and create the phospho-epitope detected in native samples. Finally, Plk1 inhibition affects kinetochore activities during prometaphase. This is different from previous studies disrupting dynactin that demonstrate an effect at the metaphase/anaphase transition. Together these studies suggest that Plk1 is a mitotic dynein kinase required for recruitment of dynein to kinetochores (Fig. 7) .
Dynein Complexity at Kinetochores:
Two major models have emerged to explain the complexity of dynein-binding proteins at kinetochores [24] . The first predicts that multiple populations of dynein co-exist at kinetochores and are recruited by different mechanisms. The second model predicts that dynein is recruited through a single mechanism but undergoes a series of transitions after recruitment. This study provides insight into these two models.
Inhibition of Plk1 depletes kinetochores of pT89 dynein but does not reduce accumulation of dephosphorylated dynein completely. The identity of this BTO-1-resistant population was revealed after dynactin depletion which reduced total dynein levels to background after BTO-1 treatment. Therefore, kinetochores contain a phosphorylated population of dynein (pT89) bound to zw10 [1] and a dephosphorylated population bound to dynactin (this study). However, it remains unclear if kinetochore dynactin recruits dephosphorylated dynein independent of the pT89 pathway. Current models suggest that the population of dynein coupled to dynactin is responsible for poleward streaming at metaphase and that this streaming is required for silencing of the SAC in response to chromosome alignment [1]. Furthermore, this dephosphorylated dynein is produced from pT89 dynein by PP1γ in response to kinetochore stretch [1] . It is possible that the dephosphorylated dynein detected in these studies represents residual dynein that was recruited before complete inhibition of Plk1. This possibility reflects the limitations of Plk1 inhibition which cannot be initiated until spindle assembly has been accomplished. This scenario is likely given the kinetics of dynein recruitment to kinetochores once NEB is activated [1] . Future experiments will be needed to test this explanation. However, because checkpoint silencing is already linked to a dynein-dynactin complex derived from the pT89 pathway, it remains unclear what the contribution of a dyneindynactin population independent of the pT89 pathway might be.
Plk1 as a Dynein Kinase:
The finding that the dynein ICs are a substrate for Plk1 is intriguing in light of the proposed roles of Plk1 phosphorylation during mitosis. Plk1 is required for spindle pole separation and spindle assembly during prophase [25] (Fig. 7) .
Dynein Functions During Prometaphase:
Other than studies in which dynein heavy chain constructs were used [22] , most previous studies on kinetochore dynein interfered with dynein indirectly through ATP depletion, disrupting dynactin [2] or disrupting other dynein-associated proteins [3] [4] [5] [6] [31] [32] [33] . These approaches lead primarily to problems in checkpoint silencing at metaphase, suggesting that the major role of dynein is poleward streaming [34] . Our analysis of dynein dephosphorylation supports this role [1] and demonstrates that loss of streaming leads to metaphase arrest/delay. However, the current study suggests additional roles for dynein during prometaphase that are independent of dynactin. These include microtubule capture, chromosome movement and efficient progression to metaphase, consistent with previous models [22, 35] . As a result, the ability to separate dynein functions from dynein-dynactin functions using Plk1 inhibition advances our understanding of kinetochore dynein activity and the role of dynein-accessory proteins. 
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ABBREVIATIONS:
AS ( A) NRK2 cells treated with vehicle control (panels 1-6) or BTO-1 (panels 7-12) were stained for phosphorylated dynein (PT89) or total dynein (red) and chromatin (blue). Both PT89 dynein and total dynein were reduced significantly at kinetochores after Plk1 inhibition (p= 5.16 x 10 -20 for pT89; p= 5.86 x 10 -10 for total dynein). However, some total dynein staining remained after BTO-1 treatment. Intensity scales correspond to 0-2500 (panels 1&7) and 0-3000 for total dynein (panels 4 &10). Mag. bar = 5 µm.
B) Control NRK2 cells and NRK2 cells expressing shRNA plasmid against p150
Glued were both treated with BTO-1 and stained for total dynein (red) and chromatin (blue). Whereas control cells retain some total dynein after BTO-1 treatment (panels 1-3), dynein levels are reduced (p= 2.26 x 10 -6) to background in cells depleted of p150 Glued and treated with BTO-1 (panels 4-6). Intensity scales correspond to 0-1500 (panels 1&4) Mag. bar = 5 µm. HeLa cells treated with vehicle control (panels 1-9) or BTO-1 (panels 10-18) were stained for chromatin (blue) and p150
Glued (panels 1-3; 10-12 -red), Zw10 (panels 4-6; 13-15-red), or spindly (panels 7-9; 16-18-red). None of these proteins were affected significantly by Plk1 inhibition (p> 0.05 for all three). Intensity scales correspond to 0-4095 (panels 1&10), 0-250 (panels 4&13) or 0-2500 (panels 7 &16). Mag. bar = 5 µm. A) Wild-type and T89A recombinant IC-2C (A.A. 1-284) was subjected to in vitro phosphorylation reactions with γ 32 P-ATP and purified Plk1 (Plk1 A -Cell Signaling; Plk1 BCedarlane). Equal protein loading was confirmed by CBB staining of the gel. B) Phosphorylation efficiency was measured using the specific activity of γ 32 P-ATP and IC protein concentration. P-value was calculated from 4 experiments. C) Wild-type and T89A recombinant IC-2C (A.A. 1-284) was probed by western blot with the pT89 phospho-antibody before ("-" lanes) or after ("+" lanes) Plk1 phosphorylation in vitro. Equal loading was confirmed by CBB staining of gels run in parallel. NRK2 cells expressing mCherry-H2B were subjected to live-cell imaging after treatment with vehicle control (control) or BTO-1 (BTO-1). To overcome effects of Plk1 inhibition during prophase, cells were treated at NEB and then imaged at 30 sec. intervals until the metaphase/anaphase transition. Control cells achieved alignment in ~ 15 min. after NEB, whereas treated cells failed to achieve alignment within 30 min. after treatment (p<0.05). The most common phenotype in inefficient progression to chromosome alignment. Mag. bar = 5 µm. NRK2 cells were monitored by DIC microscopy until chromosome alignment was achieved (panels 3,13) and chilled in the presence of a vehicle control (panels 1-10) or BTO-1 (panels [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Cells were re-warmed (panels 4-6,14-16), fixed and stained for α-tubulin (panels 7,17), pT89 dynein (panels 8,18) and chromatin (panels 9,19). Previous work suggested that phosphorylated dynein was recruited to kinetochores through a direct interaction with the rod-zw10-zwilch complex (RZZ) [1] . However, the requirement for phosphorylation was difficult to test without kinase candidates. This study identifies Plk1 as a mitotic dynein kinase that is required for recruitment of phospho-dynein. This study provides a novel method to separate the contributions of dynactin from those of dynein alone. It also has implications for the application of Plk1 inhibition as an anti-cancer therapy. 
